Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
British Journal of Clinical Pharmacology|November 22, 2025
Translation of a physiologically-based pharmacokinetic model for dabigatran etexilate to the design of a safety and efficacy study in post-partum womenKayode Ogungbenro, Lorna Aucott, Farhad Kamali, et al.Clinical Pharmacology and Therapeutics|August 11, 2025
Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3-O-Sulfate (GCDCA-S) as Endogenous Biomarker of OATP1B3 and OAT3 TransportersYuki Ujihira, Viktor Georgiev, Kayode Ogungbenro, et al.The AAPS Journal|October 9, 2020
Simultaneous Ivabradine Parent-Metabolite PBPK/PD Modelling Using a Bayesian Estimation MethodJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.CPT: Pharmacometrics & Systems Pharmacology|January 29, 2026
Population Physiologically-Based Pharmacokinetic Modeling to Determine Ontogeny: A Quantitative Clinical Pharmacology Example in Pediatric Rare DiseaseYumi Cleary, Bhagwat Prasad, Kayode Ogungbenro, et al.British Journal of Clinical Pharmacology|June 23, 2011
The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factorsSteven Lane, Sameh Al-Zubiedi, Ellen Hatch, et al.Clinical Pharmacology and Therapeutics|December 7, 2020
Impact of Hepatic CYP3A4 Ontogeny Functions on Drug-Drug Interaction Risk in Pediatric Physiologically-Based Pharmacokinetic/Pharmacodynamic Modeling: Critical Literature Review and Ivabradine Case StudyJennifer Lang, Ludwig Vincent, Marylore Chenel, et al.The Journal of Pharmacy and Pharmacology|May 25, 2019
An evaluation of cetuximab dosing strategies using pharmacokinetics and cost analysisKayode Ogungbenro, Alkesh Patel, Mark Saunders, et al.Journal of Biopharmaceutical Statistics|July 9, 2008
Analytical expressions for combining population pharmacokinetic parameters from different studiesAristides Dokoumetzidis, Leon AaronsJournal of Pharmacokinetics and Pharmacodynamics|November 26, 2009
A method for robust model order reduction in pharmacokineticsAristides Dokoumetzidis, Leon AaronsJournal of Biopharmaceutical Statistics|September 22, 2007
Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertaintyAristides Dokoumetzidis, Leon AaronsPageof 17